NC6's Principal Activity is the research and development, and promotion of the Company's microbial cellulose technology.
|Bid / Ask||-|
|Volume (4w avg)|
|vs Sector (1yr)||+406.89%|
|vs ASX 200 (1yr)||+372.03%|
|ASX Rank||1936 of 2,560|
|Sector Rank||160 of 177|
Nanollose Limited (NC6) is an Australian based biotechnology company that deals in the research and development, and promotion of the Company's microbial cellulose technology. The primary focus has been directed towards the development of the Company's Plant-Free viscose-rayon fibre (Nullarbor). The Company also continued its activities towards developing a commercial supply chain of microbial cellulose from a variety of waste streams.
No incorporation details available.
|No dividends paid.|
See Upcoming Dividends for all ASX companies.
|Ms Heidi Beatty||Non-Executive Director||Jul 2019||
Ms Heidi Beatty
Ms Beatty is founder of Crown Abbey Ltd and has 20 years' experience developing consumer and health care products. Heidi worked with Johnson & Johnson for 10 years in Europe and the US. In 2015 Heidi founded Crown Abbey Ltd.
|Mr Terence (Terry) Walsh||Non-Executive Director||Aug 2016||
Mr Terence (Terry) Walsh
Mr Walsh has more than 20 years of experience in project development, mining and general commercial law. He initially worked with law firms in Perth and Sydney before moving in house, where he has worked as the General Counsel of Hancock Prospecting Pty Ltd and prior to that as a Corporate Counsel with Rio Tinto Ltd.
|Dr Wayne Morris Best||Executive Chairman,Executive Director||Sep 2014||
Dr Wayne Morris Best
Executive Chairman,Executive Director
Dr Best has 36 years' experience in organic chemistry both in academia, government and industry. He then spent two years at Imperial College in the UK where he obtained a DIC, followed by a year at the Australian National University in Canberra. He then took up a position with ICI Australia's Research Group in Melbourne for four and a half years which included a secondment to ICI Agrochemicals' in the UK. Following ICI, Wayne returned to Western Australia and spent ten years at the Chemistry Centre (WA) where he was responsible for the formation and running of the Medicinal & Biological Chemistry Section which undertook collaborative R&D into drug discovery and contract synthesis for the drug discovery and pharmaceutical industries. He then founded Epichem Pty Ltd which he managed for 14 years before moving to Nanollose. He is currently Epichem's non-executive chairman. He has served as a Director for several listed and unlisted biotechnology companies.
|Mr Winton William Willesee||Non-Executive Director||Sep 2014||
Mr Winton William Willesee
Mr Willesee is an experienced corporate professional with experience in strategy, company development, corporate governance, company public listings, merger and acquisition transactions and corporate finance. Mr Willesee has experience with ASX listed and other companies over a range of industries, having held directorships, chairmanships and company secretarial positions with a number of ASX-listed companies over many years.
|Ms Erlyn Dale||Company Secretary||N/A|
NC6 directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
|14/01/21||Winton Willesee||Buy||+170,000||$0.083||$14,110||On-market trade|
|04/12/20||Raffaele (Alfie) Germano||Issued||2,000,000||$0.049||$98,000||Director remuneration|
|04/12/20||Raffaele (Alfie) Germano||Issued||146,796||$0.026||$3,750||Director remuneration|
|04/12/20||Raffaele (Alfie) Germano||Issued||500,000||$0.049||$24,500||Conversion of securities|
|04/12/20||Raffaele (Alfie) Germano||Exercise||500,000||$0.049||$24,500||Conversion of securities|
|04/12/20||Terence (Terry) Walsh||Issued||68,504||$0.026||$1,750||Director remuneration|
|04/12/20||Winton Willesee||Issued||68,504||$0.026||$1,750||Director remuneration|
|04/12/20||Heidi Beatty||Issued||500,000||$0.049||$24,500||Director remuneration|
|04/12/20||Heidi Beatty||Issued||68,504||$0.026||$1,750||Director remuneration|
|04/12/20||Wayne Best||Issued||2,000,000||$0.049||$98,000||Director remuneration|
|04/12/20||Wayne Best||Issued||146,796||$0.026||$3,750||Director remuneration|
|13/05/20||Winton Willesee||Issued||2,237,143||$0.024||$53,691||Rights issue|
|13/05/20||Wayne Best||Issued||2,367,144||$0.024||$56,811||Rights issue|
|13/05/20||Terence (Terry) Walsh||Issued||200,000||$0.024||$4,800||Rights issue|
|13/05/20||Raffaele (Alfie) Germano||Issued||200,000||$0.024||$4,800||Rights issue|
|20/11/19||Wayne Best||Issued||2,000,000||$0.071||$142,000||Issue of securities|
|20/11/19||Raffaele (Alfie) Germano||Issued||2,000,000||$0.071||$142,000||Issue of securities|
|02/05/19||Wayne Best||Buy||+100,000||$0.063||$6,320||On-market trade|
|04/12/18||Wayne Best||Buy||+100,000||$0.097||$9,700||On-market trade|
|28/06/18||Wayne Best||Buy||+100,000||$0.135||$13,517||On-market trade|
|25/05/18||Gary Cass||Issued||1,285,715||$0.01||$12,857||Rights issue|
|25/05/18||Wayne Best||Issued||1,404,465||$0.01||$14,045||Rights issue|
|25/05/18||Raffaele (Alfie) Germano||Issued||125,000||$0.01||$1,250||Rights issue|
|25/05/18||Winton Willesee||Issued||1,398,215||$0.01||$13,982||Rights issue|
|25/05/18||Terence (Terry) Walsh||Issued||125,000||$0.01||$1,250||Rights issue|
The current holdings of NC6 directors.
|Director||Last Notice||Direct Shares||Indirect Shares||Options||Convertibles|
|Terence (Terry) Walsh||04/12/2020||700,000||68,504||1,625,000||N/A|
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
|Name||Last Notice||Total Shares||Shares Held (%)|
|Azalea Family Holdings Pty Ltd||01/08/2020||5,517,857||7.36|
12 month transaction history compiled from ASX announcements.
|Date||Name||Bought||Previous %||New %|
12 month transaction history compiled from ASX announcements.
|Date||Name||Sold||Previous %||New %|
|21-05-20||Suzanne Margaret Cass||5,142,857||6.86||--|
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.